Related Experiment Video

Updated: Jul 26, 2025

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.2K

Timing and sequence of vaccination against COVID-19 and influenza - Author's reply

Elisabeth A Dulfer1,2, Büsra Geckin1,2, Esther J M Taks1,2

  • 1Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.

The Lancet Regional Health. Europe
|June 20, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

25.3K
An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

36.2K

Related Experiment Videos

Last Updated: Jul 26, 2025

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.2K
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

25.3K
An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

36.2K

Related Concept Videos

Vaccinations01:51

Vaccinations

44.8K
Overview
44.8K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

830
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
830
Viral Recombination00:57

Viral Recombination

23.6K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.6K

Articles linked to this work by shared authors, journal, and citation graph.

ACC1 inhibition enhances BCG-induced trained immunity by reprogramming acetyl-CoA metabolism.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Salivary polyreactive and SARS-CoV-2-specific antibody responses following SARS-CoV-2 infection and vaccination in healthcare workers.

Clinical immunology (Orlando, Fla.)·2026

Geospatial Tracking of a Rabies Outbreak in the Eastern Cape Province, South Africa, Using Molecular Data.

Transboundary and emerging diseases·2026

Evaluating mucosal and systemic immunity in an observational cohort of South African children hospitalized with acute respiratory tract infections.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Age-related differences in immune responses to inactivated influenza and adjuvanted recombinant herpes zoster vaccines.

JCI insight·2026

Bifidobacterium-driven immunoglobulin A production in pediatric patients with IgA deficiency and recurrent respiratory tract infections.

Microbiome·2026

War-related displacement, conflict intensity, and treatment delivery factors in opioid agonist maintenance treatment discontinuation following Russia's invasion of Ukraine: a national cohort study.

The Lancet regional health. Europe·2026

Performance of estimated glomerular filtration rate equations across ethnic groups in the AIM CKD UK cohort: a multicentre cross-sectional study.

The Lancet regional health. Europe·2026

The HIV care continuum and determinants of antiretroviral therapy initiation among transgender women in France (1997-2023): a longitudinal cohort study.

The Lancet regional health. Europe·2026

Neurogenic gastrointestinal, urinary, and sexual dysfunction in multiple sclerosis: a multidisciplinary framework for clinical practice.

The Lancet regional health. Europe·2026

Acute viral bronchiolitis before and after implementation of nirsevimab prophylaxis in Italy: a multicentre retrospective cohort study.

The Lancet regional health. Europe·2026

Effectiveness of a nature-based social prescribing intervention on loneliness and health-related quality of life among vulnerable urban adults (RECETAS-BCN): an observer-blinded randomised controlled trial.

The Lancet regional health. Europe·2026

Pre-Pandemic Scientific Insights into Influenza A (H3N2): Viral Evolution, Host Responses, and Evidence-Based Preventive Strategies.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026

Targeting of NLRP3 Gln624/Ser658 by Carabrone attenuates inflammatory diseases.

European journal of pharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us